| Characteristic | SARS‐CoV‐2 test result | Positive results, by specimen type | ||||
|---|---|---|---|---|---|---|
| Participants | Not detected | Detected |
Saliva and swab |
Saliva only | Swab only | |
| Number of participants | 1050 | 996 (95%) | 54 (5%) | 19 (35%) | 20 (37%) | 15 (28%) |
| Laboratory site | ||||||
| Royal Children’s Hospital | 301 (29%) | 261 (87%) | 40 (13%) | 11 (28%) | 17 (43%) | 12 (30%) |
| Primary care sites | 749 (71%) | 735 (98%) | 14 (2%) | 8 (57%) | 3 (21%) | 3 (21%) |
| Fixed site | 575 (77%) | 563 (98%) | 12 (2%) | 7 (58%) | 2 (17%) | 3 (25%) |
| Drive‐through | 174 (23%) | 172 (99%) | 2 (1%) | 1 (50%) | 1 (50%) | 0 |
| Age group (years) | ||||||
| < 5 | 129 (12%) | 114 (88%) | 15 (12%) | 2 (13%) | 5 (33%) | 8 (53%) |
| 5–9 | 47 (5%) | 43 (92%) | 4 (9%) | 0 | 2 (50%) | 2 (50%) |
| 10–17 | 36 (3%) | 34 (94%) | 2 (6%) | 0 | 1 (50%) | 1 (50%) |
| ≥ 18 | 838 (80%) | 805 (96%) | 33 (4%) | 17 (52%) | 12 (36%) | 4 (12%) |
| Sex | ||||||
| Male | 375 (36%) | 345 (92%) | 30 (8%) | 12 (40%) | 9 (30%) | 9 (30%) |
| Female | 432 (41%) | 412 (95%) | 20 (5%) | 4 (20%) | 10 (50%) | 6 (30%) |
| Unknown | 243 (23%) | 239 (98%) | 4 (2%) | 3 (75%) | 1 (25%) | 0 |
| Risk factors (N = 298*) | ||||||
| Close contact | 168 (56%) | 146 (87%) | 22 (13%) | 3 (14%) | 10 (46%) | 9 (41%) |
| Health care worker in household | 12 (4%) | 9 (75%) | 3 (25%) | 0 | 2 (67%) | 1 (33%) |
| Recent positive test | 22 (7%) | 12 (55%) | 10 (46%) | 6 (60%) | 1 (10%) | 3 (30%) |
| No identified risk factor | 107 (36%) | 101 (94%) | 6 (6%) | 0 | 6 (100%) | 0 |
| Symptoms † (N = 465) | ||||||
| No | 199 (43%) | 180 (91%) | 19 (10%) | 1 (5%) | 9 (47%) | 9 (47%) |
| Yes (any) | 266 (57%) | 247 (93%) | 19 (7%) | 8 (42%) | 8 (42%) | 3 (16%) |
| Sore throat | 107 (23%) | 101 (94%) | 6 (6%) | 3 (50%) | 2 (33%) | 1 (17%) |
| Cough | 103 (22%) | 94 (91%) | 9 (9%) | 6 (67%) | 2 (22%) | 1 (11%) |
| Fatigue | 55 (12%) | 51 (93%) | 4 (7%) | 1 (25%) | 2 (50%) | 1 (25%) |
| Fever | 53 (11%) | 47 (89%) | 6 (11%) | 3 (50%) | 2 (33%) | 1 (17%) |
| Runny nose (N = 298‡) | 93 (31%) | 88 (95%) | 5 (5%) | 2 (40%) | 3 (60%) | 0 |
| Headache (N = 298‡) | 30 (10%) | 26 (87%) | 4 (13%) | 3 (75%) | 1 (25%) | 0 |
*
Royal Children’s Hospital participants assessed only, none of whom reported recent international travel.
†
Less frequent symptoms: myalgia, 31 (6%); diarrhoea, 15 (3%); dyspnoea, 12 (2%); anosmia, four (1%); confusion, three (1%); dysgeusia, two (< 0.1%).
‡
Royal Children’s Hospital participants assessed only.